Back

Identification of residual inflammatory cardiovascular risk.

25 August 2018 (15:48 - 16:03)
Organised by:
Congress Presentation Part of: Emerging evidence-based approaches to reduce residual atherosclerotic risk Secondary Prevention Open Access ESC Congress 2018

About the speaker

Photo
Professor Jan H Cornel

Northwest Clinics, Alkmaar (Netherlands (The))

5 More presentations in this session

Presentation thumbnail
Welcome and Introduction - Emerging evidence-based approaches to reduce residual atherosclerotic risk.
Professor W. Koenig (Munich, DE)
Slides Video
Presentation thumbnail
Inflammation in atherosclerosis: time for translation?
Professor P. Libby (Boston, US)
Slides Video
Presentation thumbnail
Therapeutic strategies for secondary cardiovascular disease prevention.
Doctor P. Ridker (Boston, US)
Slides Video
Presentation thumbnail
Audience Q&A and panel discussion.
Professor P. Libby (Boston, US) Professor W. Koenig (Munich, DE) Professor J. Cornel (Alkmaar, NL) Doctor P. Ridker (Boston, US)
Slides Video
Presentation thumbnail
Learning points and close - Emerging evidence-based approaches to reduce residual atherosclerotic risk.
Professor W. Koenig (Munich, DE)
Slides Video

Access the full session

Session thumbnail
Emerging evidence-based approaches to reduce residual atherosclerotic risk

The Event

Event poster

ESC Congress 2018

25 August 2018 15:48 CET
You may be interested in
thumbnail
Webinar
Personalised secondary prevention post-ACS: the role of biomarkers
thumbnail
Webinar
Aspirin treatment for mitigating thrombotic risk across the cardiovascular risk continuum
thumbnail
Congress Presentation
Optimal medical therapy for primary prevention

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources